Cargando…
Prevalence and clinical impact of cachexia in chronic illness in Europe, USA, and Japan: facts and numbers update 2016
Cachexia is a serious clinical consequence of almost all chronic diseases when reaching advanced stages. Its prevalence ranges from 5–15% in end‐stage chronic heart failure to 50–80% in advanced malignant cancer. Cachexia is also frequently occurring in patients with chronic kidney disease, chronic...
Autores principales: | von Haehling, Stephan, Anker, Markus S., Anker, Stefan D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5114624/ https://www.ncbi.nlm.nih.gov/pubmed/27891294 http://dx.doi.org/10.1002/jcsm.12167 |
Ejemplares similares
-
Prevalence, incidence and clinical impact of cachexia: facts and numbers—update 2014
por: von Haehling, Stephan, et al.
Publicado: (2014) -
Cachexia research in Japan: facts and numbers on prevalence, incidence and clinical impact
por: Konishi, Masaaki, et al.
Publicado: (2016) -
Weight loss, malnutrition, and cachexia in COVID‐19: facts and numbers
por: Anker, Markus S., et al.
Publicado: (2020) -
Cachexia as a major underestimated and unmet medical need: facts and numbers
por: von Haehling, Stephan, et al.
Publicado: (2010) -
Kidney function in cachexia and sarcopenia: Facts and numbers
por: Okamura, Masatsugu, et al.
Publicado: (2023)